CompletedInterventionalNot ApplicableLast updated Dec 17, 2019

Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

A Comparison of Pegfilgrastim (Neulasta®) Application Via Manual Injection Versus Injection Via an On-body Injector Regarding Patient Preference and Health Economics

Overview

ClinicalTrials.gov ID: NCT03619993
Lead Sponsor: iOMEDICO AGINDUSTRY
Brief Summary: The study aims to compare two application forms (pre-filled syringe and On-body injector) of the same active drug (pegfilgrastim) in adult patients under chemotherapy regarding patient preference and health economics. Chemotherapy will be supported with pegfilgrastim for four subsequent chemotherapy cycles using alternating application forms.
Study Type

Status

Overall Status: Completed
Start Date: Jun 25, 2018Actual
Primary Completion Date: Sep 10, 2019Actual
Completion Date: Sep 10, 2019Actual

Study Record Dates

First Submitted: Jun 19, 2018
First Submitted that Met QC Criteria: Aug 2, 2018
First Posted: Aug 8, 2018Actual
Last Update Submitted that Met QC Criteria: Dec 16, 2019
Last Update Posted: Dec 17, 2019Actual
Last Verified: Dec 2019

NCT05910164Completed

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim

NCT03511378Completed

Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer

NCT02589301Completed

Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations

NCT03404752Unknown status

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

NCT00306111Completed

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

NCT01285219Completed

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy